Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-05-13FDA Approved: TRETINOIN CREAM — Supplemental Application (Obagi Cosmeceuticals LLC)
FDA approved Obagi Cosmeceuticals LLC's supplemental application for Tretinoin Cream, updating the product labeling under the NDA.
-
FDA approval · 2016-05-13FDA Approved: TRETINOIN CREAM — Supplemental Application (Obagi Cosmeceuticals LLC)
FDA approved a supplemental application for Tretinoin Cream from Obagi Cosmeceuticals LLC.
-
FDA approval · 2016-05-13FDA Approved: TRETINOIN CREAM — Supplemental Application (Obagi Cosmeceuticals LLC)
FDA approved a supplemental application for Tretinoin Cream from Obagi Cosmeceuticals LLC. The action indicates an update to the product's a…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels [Phase 3]
Phase 3 clinical trial comparing two clindamycin 1%/benzoyl peroxide 5% topical gels for acne vulgaris has completed with results posted in …
-
FDA approval · 2016-03-25FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for ACANYA, a combination of clindamycin phosphate and benzoyl peroxide, manufactured by Bausch …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-03-25FDA Approved: ZIANA — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for ZIANA (clindamycin phosphate and tretinoin) submitted by Bausch Health US, LLC.
-
FDA approval · 2016-03-23FDA Approved: ZIANA — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for ZIANA, a topical combination of clindamycin phosphate and tretinoin, submitted by Bausch Health …
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes [Phase 4]
Phase 4 trial update evaluating Epiduo Gel for reducing antibiotic-sensitive and antibiotic-resistant Propionibacterium acnes strains; study…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris [Phase 4]
Phase 4 clinical trial update of a combination therapy with Differin Gel 0.3% and Duac (clindamycin/benzoyl peroxide) for acne vulgaris show…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris [Phase 4]
Phase 4 trial update on Adapalene BPO Gel Pump, Moisturizer SPF 30, and Foam Wash in mild to moderate acne vulgaris; study completed with re…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne [Phase 3]
Phase 3 study evaluating a moisturizer containing Licochalcone A, L-carnitine and 1,2-decanediol with adapalene gel for acne; results were p…
-
FDA approval · 2016-02-24FDA Approved: ACZONE — Original Application (Almirall, LLC)
The FDA approved Aczone (dapsone) topical gel 5% for the treatment of acne vulgaris in patients 12 years and older. This submission represen…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne
This completed trial evaluates the efficacy of Epiduo (adapalene and benzoyl peroxide) in adolescent patients with inflammatory acne and exa…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Long-term Study of Epiduo in Patients With Moderate to Severe Acne
Long-term clinical trial update for Epiduo in moderate-to-severe acne, noting that the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne
A completed clinical trial evaluating Epiduo PUMP for inflammatory acne in daily practice.
-
FDA approval · 2016-02-04FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals Inc.
-
FDA approval · 2016-02-04FDA Approved: ISOTRETINOIN — Supplemental Application (Mayne Pharma)
The FDA approved Mayne Pharma's supplemental application for isotretinoin.
-
FDA approval · 2016-02-04FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ABSORICA (isotretinoin) from Sun Pharmaceutical Industries, resulting in changes to the product …
-
FDA approval · 2016-02-04FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc. The action concerns the existing iso…
-
FDA approval · 2016-02-04FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Zenatane (isotretinoin) submitted by BluePoint Laboratories.
-
FDA label_change · 2016-02-04FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) from Teva Pharmaceuticals USA, Inc., indicating an approved change t…
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Effect of Acne Vulgaris on Quality of Life of Teenagers Compared to Parent Perceived Effect on Quality of Life
A completed clinical trial evaluating how acne vulgaris affects teenagers' quality of life and comparing teen-perceived QoL with parent-perc…
-
FDA approval · 2016-01-05FDA Approved: ADAPALENE — Original Application (CALL INC. (dba Rochester Pharmaceuticals))
FDA approved a generic version of adapalene under ANDA 204593, allowing CALL INC. (dba Rochester Pharmaceuticals) to market adapalene for ac…
-
FDA approval · 2015-12-23FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for ABSORICA (isotretinoin) submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-12-17FDA Approved: TRETINOIN CREAM — Supplemental Application (Obagi Cosmeceuticals LLC)
FDA approved a supplemental application for tretinoin cream by Obagi Cosmeceuticals LLC, updating its labeling.